Editor’s note: This is a developing news story. Please check back soon for updates.
Alcon plans to acquire STAAR Surgical through a definitive merger agreement, according to a press release.
The acquisition is expected to be complete in approximately 6 to 12 months and will include STAAR’s EVO family of Implantable Collamer Lenses for myopia correction.
According to the release, the transaction’s total equity value is approximately $1.5 billion, with Alcon set to purchase all outstanding shares of STAAR common stock for $28 per share in cash.
The transaction, which is not